Covid-19 Pharma Insights
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks.
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics.
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics.
26 Jul 2022
Opinion: Pandemic preparedness
Martin Stocks, CEO of Iceni Glycoscience, discusses how preparedness for the pandemic relies on leveraging the technologies and insights of innovative startups.
25 May 2022
The MedTalk Podcast - How iiCON is driving innovation in the UK and beyond
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic.
1 Feb 2022
The future of Covid-19 vaccinations
Ivor Campbell managing director of Snedden Campbell discusses the future of Covid-19 vaccination and why testing is crucial amidst falling antibody levels.
30 Nov 2021
PrecisionLife and Metrodora Institute Partner
PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.
26 Feb 2024
Osivax Announce First-in-Human Phase 1 Vaccination Trial
Osivax have announced that the first participant has been vaccinated in its new Phase 1 trial (NCT06128382) evaluating OVX033, a broad-spectrum sarbecovirus vaccine candidate.
15 Feb 2024
Virios Therapeutics to Develop Long Covid Therapy
Virios Therapeutics, Inc have announced plans for advancing IMC-2 (combination of valacyclovir and celecoxib) as a treatment for the fatigue, orthostatic intolerance and other symptoms associated with long covid.
24 Jan 2024
Experience. Precision for Radiopharma Logistics - Marken
Winning the race against time with precision for critical Radiopharma shipments.
The future of injectable pharma lies in topload packaging
In the fast-growing injectable pharmaceuticals market, which Markets & Markets projects will reach $1139.4 billion by 2029, one innovative approach stands out as particularly valuable: topload packaging design.
17 Apr 2025
Overcoming the challenges of constructing a new cleanroom in an old facility
Mark Wheeler, commercial director, Guardtech discusses how constructing new cleanroom facilities in older buildings can be a smart and cost-effective solution for applications looking to optimise their existing spaces.
16 Apr 2025
A new role for digital adoption platforms: ensuring compliant use of pharma GxP systems
Digital adoption platforms (a simple overlay to web/cloud-based systems) offer a practical solution, guiding users of each application, step by step, in correct, compliant data input. MAIN5’s Sabine Gölden assesses their potential.
15 Apr 2025
Advancing sustainability in laboratory operations
Broughton, a analytical testing and consultancy firm, highlights its commitment to sustainability in laboratory operations by promoting environmentally responsible practices, ethical governance, and proactive maintenance strategies.
14 Apr 2025
The role of automation in enhancing sterilisation processes
Ellie Gabel, Associate Editor for Revolutionized explains how cleaning and sterilisation are essential but often unoptimised processes within pharmaceutical facilities.
10 Apr 2025
Q&A: Artiva allogeneic NK cell therapies for treating autoimmune disease
After Artiva Biotherapeutics announced the news of cryopreserved allogeneic NK cell therapies (AlloNK) for treating autoimmune disease, European Pharmaceutical Manufacturer spoke to Fred Aslan, president and CEO to learn more.
8 Apr 2025
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Experience. Precision for Radiopharma Logistics - Marken
Winning the race against time with precision for critical Radiopharma shipments.
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00